课题基金 / 基金详情

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: A Phase 2, Double-Blind, Placebo-Controlled Study

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: A Phase 2, Double-Blind, Placebo-Controlled Study
微生物生态系统 Therapeutic-2 对重度抑郁症患者的安全性和有效性：第 2 阶段、双盲、安慰剂对照研究
批准号：
458788
负责人：
Chinna Meyyappan Arthi
金额：
$7.65万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=458788&lang=en
关键词：
Anxiety Clinical Interviewing Depression Gut-Brain Axis Microbe Therapy Phase 2 Clinical Trial Probiotics

项目摘要

项目成果

Chinna Meyyappan Arthi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The gut-brain axis (GBA) is a bidirectional signalling pathway between our brain and our gastrointestinal tract. The GBA is currently being studied because of its potential relationship with our mood, anxiety, and related symptoms. Past research on the re
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Polyphenol consumption, the gut microbiome, and the microbiota-gut-brain axis
  • 批准号：
    473895
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $0.44万
  • 财政年份：
    2022
  • 负责人：
    Chinna Meyyappan Arthi
  • 依托单位：
    University College Cork (Ireland)
海外基金